CLOSED STUDIES / Ovarian Cancer


GEICO 0103


Title

Phase II study with Gemcitabine in prolonged infusion in patients with advanced platinum-resistant epithelial ovarian cancer.


GEICO Coordinator

Dr. Belén Ojeda


Patients Recruited

41 patients


Inclusion Closing Date

February of 2005


Publication

Prolonged Infusion Of Gemcitabine In Patients With Platinum Resistant Or Refractory Recurrent Ovarian Carcinoma: A Phase II Study Of GEICO (Spanish Group For Investigation On Ovarian Cancer). B. Ojeda, A. Gonzaléz-Martín, B. Mellado, I. Bover, X. Fabregat, M. Rubio, L. Alonso, P. Lianes, C. Churruca, A. Poveda. 2005 ASCO Annual Meeting. Abstract No: 5101.